ArticleFrontiers in physiology2025
Met-enkephalin modulates the stress responses of plasma concentrations of corticosterone, delta opioid receptor binding, pro-enkephalin expression, and processing in chickens.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Met-enkephalin is a neuropeptide whose release into the circulation is enhanced by stress. There have been no studies on the effects of peripherally administered Met-enkephalin in chickens. Methods: The effects of peripheral administration of Met-enkephalin on the stress response in chickens were investigated measuring plasma concentrations of corticosterone and Met-enkephalin, together with expression of pro-enkephalin (PENK) and delta-opioid binding in the hypothalamus, anterior pituitary and adrenal glands. Results: Administration of Met-enkephalin was followed by decreases in the basal and stressed plasma concentrations of the principal glucocorticoid, corticosterone, in chickens. In addition, the increase in plasma concentrations of corticosterone evoked by restraint stress was markedly decreased when the birds were treated with Met-enkephalin. Administration of Met-enkephalin was followed by decreases in PENK expression; hypothalamic, anterior pituitary, and adrenal delta-opioid binding; and plasma concentrations of total Met-enkephalin (peptides containing Met-enkephalin motifs). There were negative relationships between plasma concentrations of corticosterone and Met-enkephalin and between those of native Met-enkephalin and total Met-enkephalin. Discussion: The ability of Met-enkephalin to attenuate the stress response of corticosterone, and probably other glucocorticoids, is novel and opens up several new lines of inquiry, including its site of action and its source.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.